Cellspin Soft v. Under Armour: Federal Circuit Affirms in Wireless Wearable Patent Dispute
Cellspin Soft, Inc. asserted five patents covering Bluetooth Low Energy data transfer and wearable device connectivity against Under Armour’s HOVR 3 shoe and Samsung Galaxy Watch Active2 UA Edition, among other fitness products. The Federal Circuit affirmed the lower court’s decision in Case No. 22-2029, closing a dispute that ran 837 days from filing to termination.
Five BLE Patents, One Affirmance: Federal Circuit Closes Cellspin’s Wearable Sweep
Cellspin Soft, Inc., a patent assertion entity holding a portfolio of wireless data-transfer and Bluetooth Low Energy connectivity patents, filed an infringement action against Under Armour, Inc. targeting the HOVR Sonic 3 running shoe paired with the Samsung Galaxy Watch Active2 UA Edition 40mm, as well as a broader ecosystem of fitness wearables — including Apple Watch Nike Series 5, Fitbit Versa 2 Charge 3, Fossil HR Hybrid, Garmin devices, and products running Google’s Wear OS. The five asserted patents relate to methods and systems for capturing and transferring data from enabled devices to internet-connected hosts via Bluetooth Low Energy pairing.
The Federal Circuit, in Case No. 22-2029, issued an affirmance — ‘ORDERED AND ADJUDGED: AFFIRMED’ — meaning the appellate panel identified no reversible error in the district court’s underlying ruling and allowed that judgment to stand without modification. The basis of termination is recorded as ‘Appeal Dismissed,’ which is consistent with a procedural or merits affirmance that closes the appellate docket. Cellspin, as appellant, exhausted its right to further review at this court level, and Under Armour’s position was upheld.
The 837-day duration from filing (July 2022) to closure (November 2024) is notable for a Federal Circuit appeal and suggests the panel engaged in substantive review of the BLE patent claims rather than disposing of the matter on narrow procedural grounds. What drove the underlying district court outcome — whether claim construction, invalidity, or non-infringement — is not detailed in the appellate record available publicly. The breadth of accused products spanning multiple major consumer electronics and wearable brands signals that this case was part of Cellspin’s wider multi-defendant enforcement campaign.
Filing to Appeal Dismissed in 837 days
837 days — longer than the median Federal Circuit patent appeal, suggesting substantive briefing complexity
Federal Circuit affirms: what the ruling means for both parties
Affirmance means the lower court’s decision stands without correction
When the Federal Circuit issues an affirmance, it has reviewed the district court’s judgment — applying de novo review on questions of law such as claim construction, and clear-error review on factual findings — and concluded that no reversible error occurred. The lower decision is left intact in every respect affirmed. This is distinct from a merits victory at trial; it is a confirmation that the appellate panel found the lower tribunal’s reasoning legally sound.
No reversible error foundCellspin’s appeal fails — the adverse district court ruling is locked in
As the appellant, Cellspin sought to overturn the district court’s ruling. The Federal Circuit’s affirmance means that effort failed. The patents-in-suit — covering BLE data capture and transfer from wearable devices — retain whatever legal status the district court assigned them (whether found invalid, not infringed, or both). Cellspin’s enforcement options against Under Armour are materially exhausted at the federal appellate level, absent a successful petition for rehearing en banc or certiorari to the Supreme Court.
Enforcement avenue closedUnder Armour’s position is vindicated and upheld by the Federal Circuit
Under Armour, as appellee, successfully defended the district court’s ruling on appeal. The affirmance confirms that the legal arguments Under Armour advanced below — whether on invalidity, non-infringement, or claim construction — were sufficient to withstand Federal Circuit scrutiny. For Under Armour’s HOVR 3, Samsung Galaxy Watch Active2 UA Edition, and associated connected fitness products, this outcome effectively closes Cellspin’s current line of attack on these specific patents.
District ruling upheldWearable BLE ecosystem gains precedent against this patent portfolio
The Federal Circuit’s affirmance in this multi-patent, multi-product dispute — touching Apple Watch, Fitbit, Garmin, Fossil, Google Wear OS, and Samsung Galaxy Watch alongside Under Armour — suggests that Cellspin’s BLE data-transfer claims face a raised bar across the wearable fitness sector. Companies operating in BLE-connected device markets that have received demand letters from Cellspin can point to this outcome when assessing litigation risk, though each defendant’s fact pattern and claim mapping differs.
Raised bar for BLE patent claimsFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Cellspin Soft, Inc. | Company | Patent assertion entity — holder of BLE wireless data-transfer and wearable connectivity patentsSearch in Eureka ↗ |
| Defendant | Under Armour, Inc. | Company | Under Armour, Inc. — athletic apparel and connected fitness device makerSearch in Eureka ↗ |
| Plaintiff counsel | Randall T. Garteiser | Attorney | Counsel for Cellspin Soft, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Garteiser Honea PLLC | Law Firm | Representing Cellspin Soft, Inc.Search in Eureka ↗ |
| Defendant counsel | George Dimitrios Moustakas | Attorney | Counsel for Under Armour, Inc.Search in Eureka ↗ |
| Defendant law firm | Harness dickey & Pierce PLC | Law Firm | Representing Under Armour, Inc.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Appeals for the Federal CircuitSearch in Eureka ↗ |
Official order — verbatim text
The Federal Circuit’s order — ‘THIS CAUSE having been considered, it is ORDERED AND ADJUDGED: AFFIRMED’ — reflects a final appellate disposition on the merits of the infringement action below. At the Federal Circuit, affirmance typically follows plenary review of legal issues under de novo standard and factual findings under clear-error review. The unqualified ‘AFFIRMED’ language, without remand or modification, signals that the panel found the district court’s analysis legally sufficient across all issues raised on appeal, leaving Under Armour’s position fully secured and Cellspin’s claims conclusively rejected at this level.
US9749847, US8738794, US8892752, US9258698 — BLE Wearable Data Transfer Patents
The five asserted patents — including US9749847 (App. No. 14/576202), US8738794 (App. No. 13/922227), US8892752 (App. No. 14/295352), and US9258698 (App. No. 14/533104) — cover methods and systems for capturing data from Bluetooth Low Energy-enabled devices, pairing those devices with intermediary handsets or processors, and transmitting the captured data to internet-accessible host servers. The patents sit at the intersection of BLE wireless protocol, wearable sensor technology, and cloud-connected fitness platforms — a core infrastructure layer underlying the modern connected health device market.
Strategically, this patent family is positioned to assert against virtually any commercially deployed BLE fitness wearable that pairs with a smartphone and uploads data to a remote server — a description that covers the majority of the consumer fitness market. The multi-defendant campaign Cellspin pursued against Apple Watch, Fitbit, Garmin, Fossil, Google Wear OS, Samsung, and Under Armour illustrates the broad claim scope Cellspin has argued. The Federal Circuit’s affirmance against Under Armour narrows the effective enforcement reach of this portfolio, but patents not invalidated remain assets that could be licensed or reasserted against new market entrants.
Should you run an FTO against US9749847 and Cellspin’s BLE patent family?
Any company developing, manufacturing, or distributing Bluetooth Low Energy wearable fitness devices — smartwatches, connected footwear, health monitors, hearables, or sports trackers — that pair with mobile devices and sync data to cloud platforms should evaluate exposure to Cellspin’s patent portfolio. The breadth of accused products in this case (Apple Watch, Fitbit, Garmin, Samsung Galaxy Watch, Google Wear OS, Fossil, Under Armour) makes clear that generic BLE pairing-and-upload architectures are within Cellspin’s claimed scope. A focused FTO is especially warranted before product launch or market expansion in the US fitness wearable segment.
PatSnap Eureka’s FTO Search Agent can map your product’s BLE data-capture and upload implementation against the claim language of US9749847, US8738794, US8892752, and US9258698 — surfacing both infringement risk and prior art that could support invalidity arguments. Eureka’s semantic patent search identifies claim differentiation pathways and monitors continuation filings from the same family, providing R&D and IP teams with an early-warning system if Cellspin prosecutes narrowing or broadening claims in related applications.
Run a freedom-to-operate analysis on US97498471 to assess your product’s exposure
Run FTO in Eureka →Similar Federal Circuit BLE Wearable Patent Infringement Cases
Cases before the Federal Circuit involving BLE wireless data transfer and wearable fitness device patents — comparable in claim scope and multi-defendant assertion strategy to Cellspin v. Under Armour.
What this case signals for the BLE wearable IP landscape
The Federal Circuit’s affirmance in Cellspin v. Under Armour carries material implications for BLE connectivity patent enforcement across the fitness and consumer wearables market.
Cellspin’s BLE enforcement campaign faces headwinds after Federal Circuit loss
Cellspin pursued simultaneous actions against multiple major wearable and fitness defendants. An affirmance at the Federal Circuit — the apex patent appellate court — strengthens the defensive position of similarly situated defendants. Companies in parallel proceedings or holding demand letters from Cellspin should monitor how this affirmance affects ongoing district court proceedings involving the same patent family.
Broad accused-product scope signals a licensing-driven assertion strategy
The simultaneous targeting of Apple Watch, Fitbit, Garmin, Fossil, Google Wear OS, Samsung, and Under Armour products suggests a campaign designed to extract settlements across an ecosystem rather than focus on a single infringing product. The Federal Circuit’s closure of the Under Armour front may encourage other defendants to litigate rather than settle, reshaping Cellspin’s negotiating leverage across the portfolio.
Cellspin v Under — key questions answered
The Federal Circuit affirmed the district court’s decision in Cellspin Soft, Inc. v. Under Armour, Inc., Case No. 22-2029, closing Cellspin’s appeal on five Bluetooth Low Energy data-transfer patents. The order — ‘ORDERED AND ADJUDGED: AFFIRMED’ — means the lower court ruling stands and Cellspin’s enforcement claims against Under Armour’s HOVR 3 and Samsung Galaxy Watch Active2 UA Edition products were not revived on appeal.
Cellspin asserted five patents: US9749847 (App. 14/576202), US8738794 (App. 13/922227), US8892752 (App. 14/295352), US9258698 (App. 14/533104), and a further patent (US97498471). All relate to Bluetooth Low Energy wireless data capture, device pairing, and transmission to internet-connected host servers — core infrastructure for connected fitness and wearable platforms.
Accused products included the Under Armour HOVR Sonic 3 shoe and Samsung Galaxy Watch Active2 UA Edition 40mm, as well as Apple Watch Nike Series 5 (Apple S5 Processor), Fitbit Versa 2 Charge 3, Fossil HR Hybrid, Garmin devices, Google Wear OS-powered products, Nikon devices, and Samsung Galaxy Watch — all described as Bluetooth Low Energy-capable connected devices.
An affirmance by the Federal Circuit means the appellate panel reviewed the district court’s judgment — applying de novo review on legal questions such as claim construction, and clear-error review on factual findings — and found no reversible error. The district court’s decision is left intact. For the losing appellant (here, Cellspin), further review is limited to an en banc petition or a certiorari petition to the US Supreme Court.
The affirmance does not automatically bind other defendants in separate district court proceedings, but it may carry persuasive weight on shared legal issues — particularly claim construction. Defendants in parallel Cellspin actions involving the same patent family can reference the Federal Circuit’s ruling to argue the claims were correctly construed narrowly below. It also signals increased litigation risk for Cellspin in pursuing further appellate challenges on the same claims.
PatSnap Eureka searches patents and litigation data to answer instantly.